Logo video2dn
  • Сохранить видео с ютуба
  • Категории
    • Музыка
    • Кино и Анимация
    • Автомобили
    • Животные
    • Спорт
    • Путешествия
    • Игры
    • Люди и Блоги
    • Юмор
    • Развлечения
    • Новости и Политика
    • Howto и Стиль
    • Diy своими руками
    • Образование
    • Наука и Технологии
    • Некоммерческие Организации
  • О сайте

Видео ютуба по тегу Expanded Access Guidance

Expanded Access
Expanded Access
Expanded Access Update – Developments at the FDA and Beyond Demo
Expanded Access Update – Developments at the FDA and Beyond Demo
Dr. Pazdur on Expanded Access
Dr. Pazdur on Expanded Access
Expanded Access Part 4: How to Complete Form FDA 3926 for Follow-Up Submissions
Expanded Access Part 4: How to Complete Form FDA 3926 for Follow-Up Submissions
Expanded Access To New Medicines:  How it Works in the U.S.
Expanded Access To New Medicines: How it Works in the U.S.
Expanded Access Part 3: How to Complete Form FDA 3926 for Initial Submissions
Expanded Access Part 3: How to Complete Form FDA 3926 for Initial Submissions
Expanded Access as a source of real-world data: An overview of FDA and EMA approvals
Expanded Access as a source of real-world data: An overview of FDA and EMA approvals
Early Access Programs - All You Need To Know | myTomorrows
Early Access Programs - All You Need To Know | myTomorrows
Towards an Expanded Access: New HBV Treatment Guidelines in China - Jidong Jia, MD, PhD
Towards an Expanded Access: New HBV Treatment Guidelines in China - Jidong Jia, MD, PhD
What is Expanded Access? How EA Programs Help in the Development of New Vaccines - Ax-S Pharma
What is Expanded Access? How EA Programs Help in the Development of New Vaccines - Ax-S Pharma
Group Expanded Access vs Individual Compassionate Use (Ax-S Pharma)
Group Expanded Access vs Individual Compassionate Use (Ax-S Pharma)
The Gleevec Expanded Access Program in Leukemia - Ax-S Pharma
The Gleevec Expanded Access Program in Leukemia - Ax-S Pharma
Farshid Dayyani, MD | Patient Case - Using the Expanded Access Program for Signatera
Farshid Dayyani, MD | Patient Case - Using the Expanded Access Program for Signatera
WIRB 50: Expanded Access
WIRB 50: Expanded Access
Story  FDA Expanded Access QDL, 10 27 17
Story FDA Expanded Access QDL, 10 27 17
Expanded access to diabetes treatment for 2023
Expanded access to diabetes treatment for 2023
An Overview of FDA's Project Facilitate Oncology Expanded Access Program
An Overview of FDA's Project Facilitate Oncology Expanded Access Program
The Value of Expanded Access from a Hospital Administrator Perspective
The Value of Expanded Access from a Hospital Administrator Perspective
How does myTomorrows help Pharma?
How does myTomorrows help Pharma?
Highlights from FDA Regulatory Developments in Clinical Trials: 2023 Recap and 2024 Forecast
Highlights from FDA Regulatory Developments in Clinical Trials: 2023 Recap and 2024 Forecast
Следующая страница»
  • О нас
  • Контакты
  • Отказ от ответственности - Disclaimer
  • Условия использования сайта - TOS
  • Политика конфиденциальности

video2dn Copyright © 2023 - 2025

Контакты для правообладателей [email protected]